Audentes Therapeutics COO Natalie Holles' 2018 pay falls 66% to $1.2M
Audentes Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 26, 2019
Audentes Therapeutics reported fiscal year 2018 executive compensation information on April 26, 2019.
In 2018, five executives at Audentes Therapeutics received on average a compensation package of $723K, a 82% decrease compared to previous year.
Average pay of disclosed executives at Audentes Therapeutics
Natalie Holles, Chief Operating Officer, received $1.2M in total, which decreased by 66% compared to 2017. 50% of Holles' compensation, or $611K, was in option awards. Holles also received $164K in non-equity incentive plan and $448K in salary.
Matthew Patterson, Chief Executive Officer, received a compensation package of $780K, which decreased by 89% compared to previous year. 69% of the compensation package, or $542K, was in salary.
Suyash Prasad, Chief Medical Officer, earned $560K in 2018.
John Gray, Chief Technology Officer, received $527K in 2018.
Thomas Soloway, Chief Financial Officer, earned $525K in 2018, a 81% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2019.